Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from OncoSil Medical Ltd ( (AU:OSL) ).
OncoSil Medical has raised new equity by issuing 4,723,060 fully paid ordinary shares at A$0.68 each to sophisticated and institutional investors via an institutional placement. The company stated that the shares were issued without a prospectus under the Corporations Act disclosure exemptions and confirmed it is compliant with its financial reporting and continuous disclosure obligations, with no excluded information on foot, effectively clearing the new stock for on-market trading.
The cleansing notice underscores that OncoSil remains in good standing with corporate governance and disclosure requirements, which may reassure investors about transparency as the company funds its commercial and clinical activities. The capital injection strengthens OncoSil’s balance sheet as it seeks to expand adoption of its CE-marked breakthrough pancreatic cancer device across existing and new markets, potentially supporting further commercial roll-out and regulatory or clinical initiatives.
The most recent analyst rating on (AU:OSL) stock is a Hold with a A$0.69 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical is a global medical device company focused on interventional oncology, aiming to improve outcomes for cancer patients through targeted intratumoural placement of Phosphorous-32 microparticles alongside chemotherapy. Its lead product, the OncoSil device for unresectable locally advanced pancreatic cancer, enables higher radiation doses directly into tumours while sparing surrounding organs, and is approved in more than 30 countries including the EU, UK, Türkiye and Israel, with commercial use already underway in several European markets.
Average Trading Volume: 35,030
Technical Sentiment Signal: Sell
Current Market Cap: A$14.85M
Learn more about OSL stock on TipRanks’ Stock Analysis page.